slotkoers
Shanghai S.E.
00:00:00 15-07-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
63,15
CNY
|
-2,31%
|
|
+8,67%
|
-34,76%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
21.414
|
24.536
|
28.444
|
15.379
|
18.184
|
11.863
|
-
|
-
|
Bedrijfswaarde
1 |
21.414
|
24.536
|
28.444
|
15.379
|
18.184
|
11.863
|
11.863
|
11.863
|
K/w-verhouding
|
60,1
x
|
94,1
x
|
88,5
x
|
46,9
x
|
37,3
x
|
19,4
x
|
15,5
x
|
12,5
x
|
Dividendrendement
|
-
|
0,33%
|
0,35%
|
0,67%
|
1,03%
|
1,62%
|
2,03%
|
1,82%
|
Marktkapitalisatie/omzet
|
16,4
x
|
18,5
x
|
14,6
x
|
7,77
x
|
7,53
x
|
4,08
x
|
3,37
x
|
2,73
x
|
Bedrijfswaarde/omzet
|
16,4
x
|
18,5
x
|
14,6
x
|
7,77
x
|
7,53
x
|
4,08
x
|
3,37
x
|
2,73
x
|
Bedrijfswaarde/EBITDA
|
62
x
|
77,7
x
|
65,2
x
|
37,4
x
|
29
x
|
16,5
x
|
13
x
|
9,68
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
396
x
|
62,2
x
|
13,7
x
|
201
x
|
53
x
|
FCF Yield
|
-
|
-
|
-
|
0,25%
|
1,61%
|
7,31%
|
0,5%
|
1,89%
|
Price to Book
|
8,65
x
|
9,4
x
|
9,66
x
|
4,78
x
|
5,03
x
|
2,94
x
|
2,58
x
|
2,23
x
|
Aantal aandelen (in duizenden)
|
186.676
|
186.676
|
187.246
|
187.246
|
187.847
|
187.847
|
-
|
-
|
Referentieprijs
2 |
114,7
|
131,4
|
151,9
|
82,13
|
96,80
|
63,15
|
63,15
|
63,15
|
Datum van publicatie
|
28/02/20
|
27/02/21
|
25/02/22
|
27/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.307
|
1.326
|
1.947
|
1.980
|
2.416
|
2.906
|
3.519
|
4.346
|
EBITDA
1 |
345,3
|
315,8
|
436,6
|
411,1
|
627,8
|
719,2
|
912,3
|
1.225
|
Bedrijfsresultaat (EBIT)
1 |
351,4
|
282,2
|
367,2
|
364,2
|
560,6
|
709,7
|
877,9
|
1.118
|
Operationele Marge
|
26,87%
|
21,28%
|
18,86%
|
18,39%
|
23,2%
|
24,42%
|
24,95%
|
25,72%
|
Resultaat voor belastingen (EBT)
1 |
358,8
|
301
|
377,3
|
367,9
|
571,2
|
720
|
888,2
|
1.128
|
Nettowinst (verlies)
1 |
303,6
|
260,8
|
324,8
|
330,6
|
487
|
612,3
|
764,2
|
949,5
|
Nettomarge
|
23,22%
|
19,66%
|
16,68%
|
16,7%
|
20,16%
|
21,07%
|
21,71%
|
21,85%
|
WPA
2 |
1,907
|
1,397
|
1,716
|
1,750
|
2,592
|
3,262
|
4,070
|
5,058
|
Free Cash Flow
1 |
-
|
-
|
-
|
38,85
|
292,6
|
867
|
59
|
224
|
FCF-marge
|
-
|
-
|
-
|
1,96%
|
12,11%
|
29,84%
|
1,68%
|
5,15%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
9,45%
|
46,6%
|
120,56%
|
6,47%
|
18,29%
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
11,75%
|
60,08%
|
141,6%
|
7,72%
|
23,59%
|
Dividend per aandeel
2 |
-
|
0,4286
|
0,5357
|
0,5500
|
1,000
|
1,025
|
1,280
|
1,150
|
Datum van publicatie
|
28/02/20
|
27/02/21
|
25/02/22
|
27/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
38,9
|
293
|
867
|
59
|
224
|
ROE (netto-inkomsten/eigen vermogen)
|
21,8%
|
10,4%
|
11,8%
|
10,8%
|
14,3%
|
15,3%
|
16,8%
|
18,1%
|
ROA (netto-inkomsten/totale activa)
|
14,4%
|
8,72%
|
9,8%
|
8,73%
|
11,8%
|
13,4%
|
14,5%
|
-
|
Totale activa
1 |
2.109
|
2.990
|
3.312
|
3.785
|
4.139
|
4.569
|
5.270
|
-
|
Nettoactief per aandeel
2 |
13,30
|
14,00
|
15,70
|
17,20
|
19,20
|
21,50
|
24,50
|
28,30
|
Cashflow per aandeel
2 |
1,350
|
1,240
|
0,9200
|
1,330
|
2,900
|
3,360
|
3,690
|
4,720
|
Capex
1 |
53,5
|
161
|
163
|
211
|
253
|
246
|
284
|
411
|
Capex/omzet
|
4,09%
|
12,13%
|
8,39%
|
10,67%
|
10,47%
|
8,45%
|
8,07%
|
9,45%
|
Datum van publicatie
|
28/02/20
|
27/02/21
|
25/02/22
|
27/02/23
|
22/02/24
|
-
|
-
|
-
|
Laatste slotkoers
63,15
CNY Gemiddelde koersdoel
100,8
CNY Spread / Gemiddelde doel +59,56% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -34,76% | 1,64 mld. | | -6,46% | 179 mld. | | -6,43% | 98,84 mld. | | -7,28% | 65,34 mld. | | +15,46% | 45,41 mld. | | -8,93% | 44,94 mld. | | +8,19% | 43,76 mld. | | +12,00% | 29,01 mld. | | +19,39% | 25,65 mld. | | -9,09% | 23,32 mld. |
Medische apparatuur, benodigdheden & distributie - Andere
|